Clinical Trials Logo

Filter by:
NCT ID: NCT05298098 Recruiting - Clinical trials for Acute Decompensated Heart Failure

Impact of Hypertonic Saline Solution on Acute Decompensated Heart Failure

HSS
Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Acute decompensated heart failure (HF) is one of the most common cardiologic issues in emergency departments. Loop diuretics have long been recognized as the key for the treatment of Acute Decompensated Heart Failure (ADHF).However, chronic treatment with diuretics may limit their response and deteriorates the renal function. The hypertonic saline solution (HSS) has been proposed in recent years as an adjunctive therapy for intravenous loop diuretics to improve or restore their initial pharmacological efficacy. In this study the investigators will evaluate the effectiveness of HSS as an adjunct to i.v. furosemide in patients admitted for AHF with renal dysfunction

NCT ID: NCT05297110 Recruiting - Hypertension Clinical Trials

Olive Leaf Extracts in the Control of Cardiovascular Risk

Atherolive
Start date: August 1, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

This study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital). Patients over 18 years of age with: 1. Arterial hypertension (hypertension). 2. Or diabetes. 3. Or one or more other cardiovascular risk factors (AHA, ESC) or risk of cardiovascular disease> 20% according to the Framingham scale (apart from hypertension and diabetes were included.

NCT ID: NCT05287633 Recruiting - Dyspepsia Clinical Trials

Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting

Start date: March 20, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

evaluate the interest of proton pump inhibitors in subjects with or with GI symptoms who intend to observe fasting in Ramadan. The investigators will compare the effectiveness of proton pump inhibitors to prevent or reduce the signs of dyspepsia during Ramadan compared to placebo.

NCT ID: NCT05264753 Recruiting - Clinical trials for Patent Ductus Arteriosus

PMCF Study to Evaluate Efficacy, Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects

Start date: December 20, 2021
Phase:
Study type: Observational [Patient Registry]

This is a retrospective and prospective, multi-center, international, post marketing follow-up study to evaluate the safety and efficacy of the Occlutech PDA by using Occlutech Occlusions-Pusher (OOP) in patients with patent ductus arteriosus defects. Efficacy and safety of implanted device(s) will be evaluated by vital signs, ECGs, and echocardiography data on baseline/implantation visit (include assessments within 36 hrs. post-procedure), Day 30 to Day 90, 6 months to 1 year, 2 years to 3 years after implantation.

NCT ID: NCT05258838 Recruiting - Psoriasis Clinical Trials

Tunisian National Registry on Psoriasis

PsoTReg
Start date: July 12, 2022
Phase:
Study type: Observational

National cross-sectional multicentric study to describe the epidemiological characteristics of patients with Psoriasis in Tunisia

NCT ID: NCT05229055 Recruiting - Acute Pain Clinical Trials

Intranasal Ketamine Versus Subcutaneous Ketamine for Treatment of Post-traumatic Acute Pain in the Emergency Department ( INVESCK )

Start date: April 15, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

Pain is the most common complaint for emergency department (ED) visit. Intranasal ketamine has been shown to provide rapid, well-tolerated, effective analgesia to emergency department (ED) patients with acute pain. few trials have studied ketamine infusion subcutaneously for pain management in trauma patients.

NCT ID: NCT05206968 Recruiting - Clinical trials for Juvenile Idiopathic Arthritis Hip

Scoring System of Structural Damage for the Hip in Juvenile Idiopathic Arthritis

hip index
Start date: January 10, 2022
Phase:
Study type: Observational

Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disease in children affecting mobility and physical function. The hip involvement represents a frequent complication in JIA patients. The assessment of hip damage becomes a mandatory step in disease monitoring. However, radiological scoring was not standardized. This study aimed to compare the two scoring systems previously proposed, examine their repeatability and their intra and inter agreement.

NCT ID: NCT05094193 Recruiting - Clinical trials for Laparoscopic Cholecystectomy

Trocar-site Infiltration Versus TAP-block

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

For symptomatic gall bladder disorders (cholelithiasis and cholecystitis), laparoscopic cholecystectomy (LC) has been considered as the gold standard treatment. However, these minimally invasive technique is associated with acute moderate pain during the 24 hours postoperative, which is routinely managed using opioids. The transversus abdominis plane (TAP) block has been used as part of a multimodal analgesia strategy. Besides, Wang et al found that TAP block is more effective than a conventional pain control, but not significatively different from another local incisional pain control that is port site infiltration.So, the aim of this study, is to compare the analgesic efficacy and safety of trocar-site infiltration with ropivacaine with ultrasound-guided TAP block following laparoscopic cholecystectomy when used as part of multimodal analgesia.

NCT ID: NCT05079880 Recruiting - Clinical trials for Laparoscopic Cholecystectomy

Effect of Caffeine on Time to Anesthetic Emergence After Laparoscopic Cholecystectomy : Randomized-controlled Trial

Start date: August 15, 2021
Phase: Phase 2
Study type: Interventional

A faster emergence from general anesthesia has a double medico-economic impact by reducing the risks of complications and optimizing the performance of surgical units. No drug has been retained for its ability to actively accelerate anesthetic emergence by antagonizing hypnotics. Thus, the aim of this study was to examine the effect of caffeine on the time to emerge from sevoflurane anesthesia for laparoscopic cholecystectomy.

NCT ID: NCT04978025 Recruiting - Clinical trials for SARS (Severe Acute Respiratory Syndrome)

Colloidal Silver, Treatment of COVID-19

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

Noble metals such as gold and silver have been appreciated for millennia not only for their beauty but also for their ability to fight diseases. Silver nanoparticles (AgNPs) have been employed as chemical drugs thanks to their unique physiochemical and chemical properties as well as biological features, such as anti-inflammatory, anti-angiogenesis, antiplatelet, antifungal, anti-cancer and antibacterial activities I